Advanced search
Publication Cover
Postgraduate Medicine Volume 122, 2010 - Issue 1
Submit an article Journal homepage
22
Views
8
CrossRef citations to date
0
Altmetric
Clinical Features

Reaching HbA1c Goals with Saxagliptin in Combination with Other Oral Antidiabetic Drugs

James R. LaSalle Medical Arts Centers, Inc., Excelsior Springs, MOCorrespondence[email protected]
, DO, FAAFP
Pages 144-152 | Published online: 13 Mar 2015

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Priscilla A. Hollander & Pamela Kushner. (2010) Type 2 Diabetes Comorbidities and Treatment Challenges: Rationale for DPP-4 Inhibitors. Postgraduate Medicine 122:3, pages 71-80.
Read now

Articles from other publishers (7)

Mengistu Bekele, Ole Frithjof Norheim & Alemayehu Hailu. (2021) Cost-Effectiveness of Saxagliptin Compared With Glibenclamide as a Second-Line Therapy Added to Metformin for Type 2 Diabetes Mellitus in Ethiopia. MDM Policy & Practice 6:1, pages 238146832110057.
Crossref
Muhammad Amin & Naeti Suksomboon. (2014) Pharmacotherapy of Type 2 Diabetes Mellitus: An Update on Drug–Drug Interactions. Drug Safety 37:11, pages 903-919.
Crossref
Soo-Yeon Lee, Jeung-Hoan Kim, Jung-Mi Park, In-Chul Lee & Jin-Young Lee. (2014) Antioxidant activity and inhibition activity against α-amylase and α-glucosidase of Smilax China L.. Korean Journal of Food Preservation 21:2, pages 254-263.
Crossref
Margaret C. Lo & M. Cecilia Lansang. (2013) Recent and Emerging Therapeutic Medications in Type 2 Diabetes Mellitus. American Journal of Therapeutics 20:6, pages 638-653.
Crossref
Wilma Erhardt, Klas Bergenheim, Isabelle Duprat-Lomon & Phil McEwan. (2012) Cost Effectiveness of Saxagliptin and Metformin versus Sulfonylurea and Metformin in the Treatment of Type 2 Diabetes Mellitus in Germany. Clinical Drug Investigation 32:3, pages 189-202.
Crossref
Lily P.H. Yang. (2012) Saxagliptin. Drugs 72:2, pages 229-248.
Crossref
André J. Scheen. (2010) Dipeptidylpeptitase-4 Inhibitors (Gliptins). Clinical Pharmacokinetics 49:9, pages 573-588.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.